Navigation Links
Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study
Date:10/24/2009

ALBUQUERQUE, N.M., Oct. 23 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD), a diagnostics company focused on the development of accurate, inexpensive and noninvasive in-vitro tests for the early detection of cancer, has met its recruitment goal for New Mexico veterans with a history of heavy smoking required to complete the Phase II clinical trial of Biomoda's early-stage diagnostic for lung cancer. The next stage of the Phase II trial calls for Biomoda to begin testing samples from already-diagnosed lung cancer patients in accordance with the study protocol approved by the U.S. Food and Drug Administration (FDA).

"More than 500 veterans volunteered to be screened with the Biomoda assay. It has been heartening to see so many men and women who served their country in the armed forces willing to help once again by participating in this important study," said John Cousins, President of Biomoda. "The study is not complete, but we are pleased with the progress to date and expect to have final data in the first half of 2010."

The Biomoda diagnostic, trademarked under the name CyPath®, is based on a patented porphyrin-based compound that binds to cancer cells and fluoresces red under ultraviolet light. Under the guidance of a respiratory therapist, study volunteers provide a deep-lung sputum sample that is screened for cancer cells with both the CyPath® assay and traditional Pap staining. Participants also undergo a CT scan.

Dr. Thomas Bauer, chief of thoracic surgery at the Helen F. Graham Cancer Center, Christiana Care Health System, in Delaware, is the Principal Investigator overseeing the Phase II clinical trial. He has lead several lung and esophageal cancer studies and heads up Christiana's participation in the International Early Lung Cancer Action Program (I-ELCAP).

Based in Albuquerque, NM, Biomoda is a cancer diagnostics company focused on the development of accurate, inexpe
'/>"/>

SOURCE Biomoda, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Clinical Lab Products Magazine Features Biomoda
2. FDA Reviewing Biomoda Submission for Cancer Screening Study
3. Small Business Innovation Research Program Awards Grant to Biomoda
4. Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting
5. Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
6. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
7. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
8. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
9. Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares
10. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
11. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Research and Markets ( ... "Stability Testing of Pharmaceuticals (London, UK - December 2-3, ... attending this comprehensive two day seminar delegates will: ... that are suitable for global arketing - Be ... stability samples and facilities - Know how to ...
(Date:9/3/2015)... Sept. 3, 2015 Report ... New Drugs, Industry Changes and Emerging Opportunities What,s ... ovaries? Visiongain,s new study forecasts those pharmaceutical revenues. ... that industry. You also explore trends, results, treatments, ... report gives revenue predictions to 2025 at overall ...
(Date:9/3/2015)... , Sept. 3, 2015 About self-monitoring ... is a home-based electronic device. It consists of ... information about glucose levels through radiowaves from the ... The regular usage of self-monitoring blood glucose devices ... individual to undergo proper diabetes treatment. ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
(Date:9/4/2015)... ... ... for a quick and convenient way to produce a hot remedy for colds. The K ... and simple way to brew a hot cup of cold remedy when desired. In doing ... comfort and health. The invention features a novel design that is lightweight, compact and portable. ...
(Date:9/4/2015)... ... 04, 2015 , ... The USC Eye Institute is proud to announce that ... Faculty, residents and staff are honored to have contributed to the success of ... ophthalmology residency program. Our faculty places a high priority on our educational programs in ...
(Date:9/4/2015)... ... 2015 , ... Having access to a doctor can sometimes be a challenge ... unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to those ... solution to alleviate this problem has recently presented itself, the new telemedicine platform and ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal with many ... Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best Practices for ... Inc. (AIS), will detail which deals are attracting the most government scrutiny and ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... led by a,team of education researchers from Mayo ... the American Medical Association (JAMA) concludes that,Internet-based education ... M.D., an associate professor of medicine who,practices general ... Mayo and McMaster University in Hamilton, Ontario. They ...
... MedImmune, the,global biologics unit of AstraZeneca, and ... Inc., announced today that they have entered,into a ... Biotech,s anti-ILT7 protein for the potential treatment of ... has,global rights to any resulting product candidates and ...
... During Hispanic Heritage Month Work to ... Population, ALEXANDRIA, Va., Sept. 11 To celebrate ... those in the,Hispanic/Latino American population who have, or are ... grant from the Abbott Fund, is,introducing its new Adult ...
... current outbreaks of listeriosis in Canada connected to ... releasing guidelines for health care professionals and the ... symptom management, and how to reduce the risk ... United States, about 20-65% of all foodborne-related deaths ...
... making waiting room time more enjoyable and informative for ... country and helping doctors become more profitable in the ... network is Ear, Nose & Throat Associates of South ... this month in Chicago at AOA-26 and OTO EXPO ...
... Texas, Sept. 11 Wound Management,Technologies, Inc., (OTC Bulletin ... of the year and for 2009. "The company,has been ... market for,the first 3 quarters of the year to ... in the world. We have been working,with several major ...
Cached Medicine News:Health News:Mayo Clinic, McMaster University Research Review Shows Internet-based Instruction Effective for Teaching Health Care Professionals 2Health News:MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech 2Health News:American Diabetes Association Announces New Latino Diabetes Toolkit 2Health News:American Diabetes Association Announces New Latino Diabetes Toolkit 3Health News:Mediplay Makes Marketing More Profitable For Physicians 2Health News:Mediplay Makes Marketing More Profitable For Physicians 3Health News:Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009 2
Scleral Blade tip 5700 style, straight. Dimensions: 15.2 mm (L) x 3.4 mm (W). Cut: 2.7 mm....
20 g MVR knife. Dimensions: 31.8 mm x 1.18 mm x 2.7 mm....
Full Handle Laseredge Slit Blade Knife, 3.5 mm angled bevel up. Blade tip dimension: 14.7 mm x 3.5 mm x 3.9 mm....
Full Handle Laseredge Slit Blade Knife, 3.0 mm angled double bevel. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Medicine Products: